Literature DB >> 16157084

Does dietary salt increase the risk for progression of kidney disease?

Shiraz I Mishra1, Charlotte Jones-Burton, Jeffrey C Fink, Jeanine Brown, George L Bakris, Matthew R Weir.   

Abstract

Due to the inconsistent observations and suboptimal quality of the study designs, there is insufficient clinical evidence to suggest that increased salt intake may adversely modify the rate of progression of kidney disease. However, there is experimental evidence to suggest a link between increased salt exposure and kidney tissue injury. Further clinical trials are needed to evaluate the relationship between dietary salt and risk for progression of chronic kidney disease.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16157084     DOI： 10.1007/s11906-005-0076-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  63 in total

1.  Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients.

Authors:  M Imanishi; K Yoshioka; M Okumura; Y Konishi; N Okada; T Morikawa; T Sato; S Tanaka; S Fujii
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

2.  Dietary salt, intracellular ion homeostasis and hypertension secondary to early-stage kidney disease.

Authors:  H Schiffl; C Küchle; S Lang
Journal:  Miner Electrolyte Metab       Date:  1996

3.  Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis.

Authors:  Y Akagi; Y Isaka; M Arai; T Kaneko; M Takenaka; T Moriyama; Y Kaneda; A Ando; Y Orita; T Kamada; N Ueda; E Imai
Journal:  Kidney Int       Date:  1996-07       Impact factor: 10.612

4.  Effect of dietary salt on arteriolar nitric oxide in striated muscle of normotensive rats.

Authors:  M A Boegehold
Journal:  Am J Physiol       Date:  1993-06

5.  The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.

Authors:  H Buter; M H Hemmelder; G Navis; P E de Jong; D de Zeeuw
Journal:  Nephrol Dial Transplant       Date:  1998-07       Impact factor: 5.992

6.  Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Authors:  W A Border; N A Noble; T Yamamoto; J R Harper; Y u Yamaguchi; M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

7.  Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.

Authors:  Y Isaka; Y Fujiwara; N Ueda; Y Kaneda; T Kamada; E Imai
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Concordance, discordance and prevalence of hypertension in World War II male veteran twins.

Authors:  D Carmelli; D Robinette; R Fabsitz
Journal:  J Hypertens       Date:  1994-03       Impact factor: 4.844

9.  Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria.

Authors:  M R Weir; D R Dengel; M T Behrens; A P Goldberg
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

10.  Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide.

Authors:  P J Shultz; J P Tolins
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808
View more
  1 in total

Review 1.  Management of hypertension in chronic kidney disease.

Authors:  Pasquale Zamboli; Luca De Nicola; Roberto Minutolo; Valerio Bertino; Fausta Catapano; Giuseppe Conte
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.